HDAC inhibition improves autophagic and lysosomal function to prevent loss of subcutaneous fat in a mouse model of Cockayne syndrome

Marc Majora, Kevin Sondenheimer, M. Knechten, I. Uthe, Charlotte Esser, Alfonso Schiavi, Natascia Ventura, Jean Krutmann

Science Translational Medicine · 2018 · 55 citations · 61 references

Concepts

Abstract

The HDAC inhibitor SAHA rescues the skin phenotype in CSB-deficient mice by enhancing protein acetylation and inducing autophagy.

References

61